H.B. Fuller Sees More M&A, But Not Yet

H.B. Fuller CEO Celeste Mastin says deleveraging will be the company's priority after its planned acquisition of Advanced Medical Solutions, while maintaining M&A as part of its long-term strategy. She also tells Dani Burger on Bloomberg Open Interest that disruptions to petrochemical supplies have had a bigger impact than tariffs.